ADMA Biologics Inc (ADMA NASDAQ) stock market data APIs
$19.7008
-0.15(-0.8%)
as of December 3, 2025
Try our APIs with
free plan!
ADMA Biologics Inc Financial Data Overview
Price chart is built with
Anychart
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Prev. Close
19.7008
Open
19.5544
High
19.9728
Low
19.2057
52 wk Range
13.5-25.67
Market Cap
4 706 M
P/E Ratio
22.9302
Shares Outstanding
238 M
Revenue
489 M
EPS
0.15
Beta
0.448
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ADMA Biologics Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ADMA Biologics Inc data using free add-ons & libraries
Get ADMA Biologics Inc Fundamental Data
ADMA Biologics Inc Fundamental data includes:
- Net Revenue: 489 M
- EBITDA: 175 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-05
- EPS/Forecast: 0.15
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ADMA Biologics Inc News
New
High Growth US Tech Stocks To Watch In December 2025
As the Dow Jones and S&P 500 approach record highs, buoyed by expectations of a potential Federal Reserve rate cut, the U.S. tech sector remains a focal point for investors navigating an evolving econ...
Zoetis Stock Plummets 24.8% YTD: Here's What You Need to Know
Shares of Zoetis ZTS have plunged 24.8% year to date, amid mounting safety concerns surrounding its monoclonal antibody osteoarthritis (OA)pain therapies — Librela for dogs and Solensia for cats. Wi...
These stocks are new additions to Mizuho’s ’Americas Top Picks’ list
Investing.com -- Mizuho has refreshed its monthly Americas Top Picks list, adding new high-conviction ideas selected by its U.S. equity analysts. The list highlights “our analysts’ highest convic...
US High Growth Tech Stocks to Watch
As the U.S. stock market navigates a complex landscape marked by recent gains in major indices like the Dow Jones Industrial Average, which added over 400 points amid mixed economic signals such as a ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
